Home
About
Overview
Sharing Data
ORCID
Help
History (39)
Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors.
Randomized trial of an intensive care unit-based early discharge planning intervention for critically ill elderly patients.
Peaceful awakenings: taking the "alarm" out of the alarm clock.
Dermatologists
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.
See All 39 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron. 2013 Apr 24; 78(2):256-68.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Alzheimer Disease
Amyloid beta-Peptides
Apolipoproteins E
Case-Control Studies
Chromosomes, Human, Pair 3
Chromosomes, Human, Pair 6
DNA-Binding Proteins
Female
Genome-Wide Association Study
Genotype
Humans
Male
Membrane Glycoproteins
Middle Aged
Muscle Proteins
Peptide Fragments
Phenotype
Phosphorylation
Polymorphism, Single Nucleotide
Receptors, Immunologic
Repressor Proteins
Risk Factors
Serine
tau Proteins
Trans-Activators
Transcription Factors
authors with profiles
David A Bennett